Michael Robert Martin - Sep 7, 2021 Form 4 Insider Report for Aurinia Pharmaceuticals Inc. (AUPH)

Role
Chief Business Officer
Signature
/s/ Michael Robert Martin
Stock symbol
AUPH
Transactions as of
Sep 7, 2021
Transactions value $
-$135,750
Form type
4
Date filed
9/8/2021, 04:04 PM
Previous filing
Aug 27, 2021
Next filing
Sep 14, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AUPH Common Stock Sale -$136K -7.5K -4.07% $18.10 177K Sep 7, 2021 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 21, 2021.